fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Atogepant shows efficacy for prevention of migraine

Written by | 14 May 2023

Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of… read more.

Why migraine frequently occurs during menstruation

Written by | 25 Feb 2023

When women suffer migraine attacks, it is often just before or during their monthly period. A team of researchers from Charité – Universitätsmedizin Berlin has now identified a… read more.

Migraine: how to diagnose, manage and prevent

Written by | 1 Feb 2023

Migraine is a major cause of disability, affecting about 12% of people. A 2-part series published in CMAJ (Canadian Medical Association Journal) on diagnosing and managing the condition with both… read more.

Lidocaine infusions show strong effect for migraine

Written by | 26 May 2022

Lidocaine infusions appear to offer significant relief to patients with refractory chronic migraine. Researchers reported this finding on May 23, 2022 in the journal Regional Anesthesia & Pain Medicine…. read more.

Largest genetic study of migraine to date reveals new genetic risk factors

Written by | 10 Feb 2022

An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine. The groundbreaking study helps researchers better… read more.

FDA approves Qulipta for prevention of migraine – AbbVie

Written by | 19 Oct 2021

The FDA has approved Qulipta (atogepant tablets), from AbbVie, for the preventive treatment of episodic migraine in adults. The approval of Qulipta was based on findings from the… read more.

BioDelivery Sciences International completes acquisition of Elyxyb for acute migraine treatment in the U.S. and Canada

Written by | 26 Sep 2021

BioDelivery Sciences International, Inc. a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced that it has completed the acquisition of U.S. and Canadian rights… read more.

Migraine tied to poorer sleep for adults and children

Written by | 23 Sep 2021

Migraines are linked to poorer quality sleep in both adults and children, researchers reported on Sept. 22, 2021 in Neurology As background to the new meta-analysis, investigator and… read more.

Consuming a diet with more fish fats, less vegetable oils can reduce migraine headaches, study finds

Written by | 26 Jul 2021

This study of 182 adults with frequent migraines expanded on the team’s previous work on the impact of linoleic acid and chronic pain. Linoleic acid is a polyunsaturated… read more.

For better migraine treatment try Yoga

Written by | 25 Jul 2021

“Migraine is one of the most common headache disorders, but only about half the people taking medication for it get real relief,” said study author Rohit Bhatia, M.D.,… read more.

Rimegepant shows efficacy in migraine prevention

Written by | 27 Dec 2020

The migraine treatment rimegepant also appears to have efficacy in preventing migraines, researchers reported on Dec. 15, 2020 in The Lancet.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.